Takeda Pharmaceutical is Japan’s leading pharmaceutical company by revenue. While the firm historically focused on the Japan market, management is undertaking an ambitious overhaul to diversify ...

Takeda Pharmaceutical, Japan’s largest drugmaker by sales, has an appetite for more acquisitions to accelerate overseas growth after saying it would spend about $5 billion to purchase U.S ...

TOKYO (Reuters) - Japan's Takeda Pharmaceutical Co said on Thursday half-year profit jumped and the drugmaker would buy back shares it viewed as undervalued.

Japan's Takeda Pharmaceutical Co said on Wednesday its drug pipeline is poised to drive annual sales up by more than 50%, to 5 trillion yen ($48.01 billion) in the next decade.

TOKYO (AP) — Tsunekazu Takeda, the president of the Japanese Olympic Committee and a powerful IOC member, again denied corruption allegations against him, suggesting on Tuesday that any guilt ...

Takeda Pharmaceutical Co (4502.T) said on Tuesday the Japanese government agreed to purchase 150 million doses of the COVID-19 vaccine it will produce using Novavax Inc's formula.

Takeda Pharmaceutical Co. said efforts to revamp its research operations will cost 75 billion yen ... The Japanese company’s R&D activities will be concentrated in Japan and in the U.S., ...

Wahei Takeda, known as the "Warren Buffet of Japan" has given probably the least stressful advice about personal finance you've read in a while.

About Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE: TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan ...